Midazolam 1 Mg/ Ml Accord 1,0 mg SOLUTION FOR INJECTION/ INFUSION
PDF Leaflet Revision Date: 13 September 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Sedation before procedures and induction/maintenance of anesthesia.
Dosage (summary)
Adults <60: 2.5 mg IV; Adults >60: 1-1.5 mg IV.
Onset of Action / Duration
Onset: 2 mins, Duration: 1-2 hours
Special Populations
- Elderly
- Debilitated patients
- Chronic respiratory insufficiency
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Not established safe in pregnancy; avoid in breastfeeding.
Key Drug Interactions
- CYP3A4 inhibitors (e.g., ketoconazole)
- CNS depressants (e.g., alcohol, opioids)
Contraindications
- Hypersensitivity to midazolam
- Severe respiratory insufficiency
- Pregnancy
Common side effects
- Drowsiness
- Amnesia
- Respiratory depression
- Hypotension
Counselling Points
- Do not drive or operate machinery post-administration.
- Accompanied discharge recommended.
Serious warnings
- Risk of severe respiratory depression
- Monitor high-risk patients closely
Important Disclaimer
The Midazolam 1 Mg/ Ml Accord 1,0 mg SOLUTION FOR INJECTION/ INFUSION professional information leaflet below is the property of Accord Healthcare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
